Theriva Biologics (TOVX) stock
Breakaway doesn't score TOVX. It is too small and priced too low for a fair Quality Score.
Follow TOVX's trial news. Pro members can get an alert when Theriva Biologics files news, and see its trials, share raises, and its CEO's filings.
We do the work for you. 3,168 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.
What's next for TOVX, and how long its cash lasts
Next step the company has named
Cash runway
About 3 quarters
Dilution on the horizon
No shelf registration or at-the-market program on file in the last three years.
Insiders
No open-market buys or sales by its officers or directors in their filings of the last year.
FDA dates in the next 60 days
Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.
TOVX's latest filings
- Theriva™ Biologics Announces Sale of SYN-004 (ribaxamase) and Related Antibiotic-Degrading Enzyme Portfolio to Biossil Labs Inc.
- Quarterly report
- 4 insider filings
Why TOVX isn't scored
The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. TOVX is worth about $7.1M and trades at $0.15. A stock that clears every mark is scored from the next weekly rebuild.
Straight AnswersStraight Answers
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.